Kura Oncology, Inc. (KURA) — Insider Activity & Signal

Healthcare · Biotechnology · Market cap $1.1B · $12.66 · 52-week range $7.36–$13.90

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-08-24	WILSON TROY EDWARD	director, officer: President and CEO	100,000	$12.39	$1,239,000	SEC Form 4
2026-08-17	WILSON TROY EDWARD	director, officer: President and CEO	100,000	$11.12	$1,112,000	SEC Form 4

Financial health

Altman Z-Score -2.51 · Piotroski F-Score 3/9 · Cash $667M · Debt $20M

ClearOcean signal read

ClearOcean's model currently scores KURA as a watchlist-level signal (6/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — KURA Form 4
How ClearOcean reads insider activity

Last updated August 31, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.